Fig. 5From: Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndromeGraphic representation of IL-1β (a) and TNF-α (b) mRNA expression in the liver in the control group (C); diabetic and high fat diet mice (HDC); diabetic and high fat diet mice treated with aliskiren (HDA). ●P < 0.05, HDC × HDA. (n = 4–6 mice per group)Back to article page